Cytek Biosciences Statistics
Total Valuation
CTKB has a market cap or net worth of $496.17 million. The enterprise value is $257.83 million.
Important Dates
The next confirmed earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CTKB has 127.22 million shares outstanding. The number of shares has decreased by -3.15% in one year.
| Current Share Class | 127.22M |
| Shares Outstanding | 127.22M |
| Shares Change (YoY) | -3.15% |
| Shares Change (QoQ) | -1.09% |
| Owned by Insiders (%) | 9.28% |
| Owned by Institutions (%) | 57.66% |
| Float | 108.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.56 |
| Forward PS | 2.39 |
| PB Ratio | 1.31 |
| P/TBV Ratio | 1.45 |
| P/FCF Ratio | 45.65 |
| P/OCF Ratio | 32.64 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 23.72 |
Financial Position
The company has a current ratio of 5.22, with a Debt / Equity ratio of 0.06.
| Current Ratio | 5.22 |
| Quick Ratio | 4.35 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | 2.18 |
| Interest Coverage | -226.62 |
Financial Efficiency
Return on equity (ROE) is -1.67% and return on invested capital (ROIC) is -4.58%.
| Return on Equity (ROE) | -1.67% |
| Return on Assets (ROA) | -3.77% |
| Return on Invested Capital (ROIC) | -4.58% |
| Return on Capital Employed (ROCE) | -7.01% |
| Revenue Per Employee | $302,523 |
| Profits Per Employee | -$9,880 |
| Employee Count | 648 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.79 |
Taxes
| Income Tax | -1.16M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.41% in the last 52 weeks. The beta is 1.32, so CTKB's price volatility has been higher than the market average.
| Beta (5Y) | 1.32 |
| 52-Week Price Change | -20.41% |
| 50-Day Moving Average | 3.93 |
| 200-Day Moving Average | 3.94 |
| Relative Strength Index (RSI) | 47.45 |
| Average Volume (20 Days) | 650,754 |
Short Selling Information
The latest short interest is 6.28 million, so 4.93% of the outstanding shares have been sold short.
| Short Interest | 6.28M |
| Short Previous Month | 6.34M |
| Short % of Shares Out | 4.93% |
| Short % of Float | 5.77% |
| Short Ratio (days to cover) | 7.46 |
Income Statement
In the last 12 months, CTKB had revenue of $196.04 million and -$6.40 million in losses. Loss per share was -$0.05.
| Revenue | 196.04M |
| Gross Profit | 106.68M |
| Operating Income | -29.46M |
| Pretax Income | -7.56M |
| Net Income | -6.40M |
| EBITDA | -21.99M |
| EBIT | -29.46M |
| Loss Per Share | -$0.05 |
Full Income StatementBalance Sheet
The company has $262.02 million in cash and $23.68 million in debt, giving a net cash position of $238.34 million or $1.87 per share.
| Cash & Cash Equivalents | 262.02M |
| Total Debt | 23.68M |
| Net Cash | 238.34M |
| Net Cash Per Share | $1.87 |
| Equity (Book Value) | 377.56M |
| Book Value Per Share | 2.97 |
| Working Capital | 309.56M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $15.20 million and capital expenditures -$4.33 million, giving a free cash flow of $10.87 million.
| Operating Cash Flow | 15.20M |
| Capital Expenditures | -4.33M |
| Free Cash Flow | 10.87M |
| FCF Per Share | $0.09 |
Full Cash Flow StatementMargins
Gross margin is 54.42%, with operating and profit margins of -15.03% and -3.27%.
| Gross Margin | 54.42% |
| Operating Margin | -15.03% |
| Pretax Margin | -3.86% |
| Profit Margin | -3.27% |
| EBITDA Margin | -11.22% |
| EBIT Margin | -15.03% |
| FCF Margin | 5.54% |
Dividends & Yields
CTKB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.15% |
| Shareholder Yield | 3.15% |
| Earnings Yield | -1.29% |
| FCF Yield | 2.19% |
Analyst Forecast
The average price target for CTKB is $6.00, which is 53.85% higher than the current price. The consensus rating is "Hold".
| Price Target | $6.00 |
| Price Target Difference | 53.85% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CTKB has an Altman Z-Score of 4.19 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.19 |
| Piotroski F-Score | 4 |
